Nanoparticles laden in situ gel for sustained ocular drug delivery

Journal of Pharmacy and Bioallied Sciences

Volumn 5, Issue 2, 2013, Pages 162-165

  Gupta, Himanshu ^a   Aqil, Mohammed ^a   Khar, Roop K ^a   Ali, Asgar ^a   Bhatnagar, Aseem ^b   Mittal, Gaurav ^b  

^a HAMDARD UNIVERSITY   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Gamma scintigraphy; in situ gel; nanoparticle; nanoparticle laden in situ gel; ocular; PLGA; sparfloxacin

Indexed keywords

CHITOSAN; METHYL PARABEN; NANOPARTICLE; POLYGLACTIN; SODIUM CHLORIDE; SPARFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORNEA; DRUG CLEARANCE; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RETENTION; GAMMA CAMERA; GAMMA SCINTIGRAPHY; GEL; GELATION; IN VIVO STUDY; MALE; NONHUMAN; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RABBIT; RADIOACTIVITY; SUSTAINED DRUG RELEASE; VISCOSITY;

EID: 84878585634     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.111824     Document Type: Article

References (14)

1. Maurice DM. Kinetics of topical applied drugs. In: Saettone MS, Bucci P, Speiser P, editors. Ophthalmic drug delivery: Biopharmaceutical, technological and clinical aspects. vol. 11. Padova: Liviana Press; 1987. p. 19-26.
2. Ding S. Recent developments in ophthalmic drug delivery. Pharm Sci Technolo Today 1998;1:328-35. (Pubitemid 28526961)
3. Hill JM, O'Callaghan RJ, Hobden JA, Kaufman E. Corneal collagen shields for ocular drug delivery. In: Mitra AK, editor. Ophthalmic drug delivery systems. New York: Marcel Dekker; 1993. p. 261-75.
4. Pleyer U, Lutz S, Jusko W, Nguyen K, Narawane M, Rückert D, et al. Ocular absorption of topically applied FK506 from liposomal and oil formulations in rabbit eye. Invest Ophthalmol Vis Sci 1993;34:2737-42. (Pubitemid 23232483)
5. Bochot A, Fattal E, Grossiord JL, Puisieux F, Couvereur P. Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel. Int J Pharm 1998;162:119-27. (Pubitemid 28166097)
6. de Campos AM, Diebold Y, Carvaiho EL, Sanchez A, Alonso MJ. Chitosan nanoparticles as new ocular drug delivery system: In vitro stability, in vivo fate, and cellular toxicity. Pharm Res 2004;21:803-10. (Pubitemid 39011304)
7. Losa C, Calvo P, Castro E, Vila-Jato JL, Alonso MJ. Improvement of ocular penetration of amikacin sulphate by association to poly (butylcyanoacrylate) nanoparticles. J Pharm Pharmacol 1991;43:548-52.
8. Losa C, Marchal-Heussler L, Orallo F, Vila-Jato JL, Alonso MJ. Design of new formulations for topical ocular administration: Polymeric nanocapsules containing metipranolol. Pharm Res 1993;10:80-7. (Pubitemid 23020842)
9. De Campos AM, Sánchez A, Gref R, Calvo P, Alonso MJ. The effect of PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci 2003;20:73-81. (Pubitemid 37103234)
10. Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems: Recent advances. Prog Retin Eye Res 1998;17:33-58. (Pubitemid 28040752)
11. Kayser O, Lemke A, Hernández-Trejo N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol 2005;6:3-5. (Pubitemid 40246748)
12. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G, et al. Development and characterization of Tc-99m timolol maleate for evaluating efficacy of in situ ocular drug delivery system. AAPS Pharm Sci Tech 2009;10:540-6.
13. Gupta H, Aqil M, Khar RK, Ali A, Mittal G, Bhatnagar A. Sparfloxacin loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine 2010;6:324-33.
14. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Levofloxacin nanoparticle laden in situ gel for control ocular drug delivery. 37 th annual meeting and exposition of the control release society, Portland, Oregon, USA; July 10-14, 2010. (Abstract 362). Available from: http://www.gbv.de/dms/tib-ub- hannover/66235561x.pdf [Last accessed on 2013 Mar 10].